The Deal That Looked Right on Paper

The offer is strong. The buyer is credible. The timeline works. And yet something about the transaction does not feel right to the owner. That instinct is worth taking seriously.

Leland Healthcare Advisors & Consultants (LHA&C) has advised clinical care business for more two decades. In that time, he has seen transactions that looked right on paper produce outcomes that damaged the organizations involved, destabilized the clinical teams delivering care, and ultimately harmed the patients those organizations existed to serve.

​

"The highest offer is not always the right offer.  In clinical care, the cost of a misaligned transaction is not simply financial. It is clinical. It is cultural. And in many cases, it is irreversible."

 

What Mission Misalignment Looks Like in Practice

Mission misalignment in clinical care M&A rarely announces itself at the negotiation table. It reveals itself after the transaction closes, in the decisions the new owner makes about staffing, service delivery, billing practices, and organizational culture.

​

A buyer who acquires a behavioral health business with the intention of significantly expanding its census without investing in clinical staffing is making a financial decision that has direct consequences for patient care quality. A buyer who acquires a home health business and immediately moves to centralize operations and reduce the autonomy of local clinical teams is making an efficiency decision that may accelerate staff departures and disrupt patient relationships. A buyer who acquires a rehabilitation services business and redirects referral relationships toward higher-margin patient populations is making a revenue decision that may exclude the communities the original organization was built to serve.

​

None of these decisions are necessarily made in bad faith. But they reflect a set of priorities that may be fundamentally misaligned with the mission of the organization being acquired — and with the expectations of the owner who built it.

 

How Mission Alignment Is Evaluated

LHA&C's approach to buyer identification and matching goes beyond financial qualification. The advisory process evaluates potential buyers across a set of dimensions that reflect the specific mission and values of the organization being transitioned: clinical philosophy and care model, track record with previous acquisitions, staffing and workforce development approach, community and referral relationship management, and long-term strategic intentions for the acquired organization.

​

This evaluation is not simply qualitative. It is structured and evidence-based. LHA&C's team reviews the operational track record of potential buyers with previous acquisitions, and structures transaction terms — including representations, warranties, and post-closing operational commitments — that create accountability for mission-aligned behavior after the deal closes.

​

The goal is not to find the buyer willing to pay the most. It is to find the buyer most likely to sustain and strengthen what the selling organization has built — and to structure the transaction in a way that gives that outcome the best possible chance of being realized.

 

Structuring for Mission Protection

Transaction structure is one of the most powerful tools available for protecting mission alignment through and beyond a clinical care ownership transition. Earnout provisions tied to clinical quality metrics, employment protections for key clinical staff, community benefit commitments embedded in transaction agreements, and governance rights that preserve the selling organization's voice in post-transaction decision-making are all mechanisms that can be used to align financial incentives with mission outcomes.

​

These structures are not standard in every healthcare transaction. They require experienced advisory support and a buyer willing to engage with mission commitments as a genuine part of the deal, not simply as negotiating theater. But for clinical care business owners who have built organizations with a genuine commitment to the communities and patients they serve, they represent the difference between a transaction that honors that commitment and one that extinguishes it.

 

The Question Worth Asking Before Any Transaction

Before any clinical care business owner enters a formal transaction process, Thompson advises them to answer one question honestly: if this buyer makes the decisions I expect them to make after this transaction closes, will I be proud of what this organization becomes?

​

If the answer is yes, the transaction is worth pursuing. If the answer is uncertain, the preparation work is not finished. And if the answer is no, the offer on the table — regardless of its size — is not the right offer.

The right buyer exists for every well-prepared clinical care business. Finding that buyer, qualifying them properly, and structuring a transaction that protects what matters most is precisely what LHA&C was built to do.